FAQ-TIL Therapy at BIOOCUS

Q.
What is TIL Therapy?

A.

TIL (Tumor-Infiltrating Lymphocyte) therapy is a form of immunotherapy where T-cells from the patient’s tumor are harvested, expanded in a lab, and then reinfused into the patient to attack cancer cells.
Q.
How long does the TIL therapy process take?

A.
The TIL therapy process typically takes about 6-8 weeks. The initial step of tumor tissue collection and T-cell cultivation in the laboratory takes 3-4 weeks, followed by chemotherapy conditioning and TIL infusion.
Q.
What types of cancer can be treated with TIL therapy?

A.
TIL therapy is primarily used for solid tumors such as melanoma, lung cancer, cervical cancer, and some other advanced or metastatic cancers. Eligibility is based on tumor type and response to prior treatments.
Q.
What side effects should I expect from TIL therapy?

A.
Side effects of TIL therapy may include fatigue, fever, nausea, and cytokine release syndrome (CRS). As with CAR-T, the treatment is closely monitored to ensure patient safety.
Q.
How do I prepare for TIL therapy?

A.
Similar to CAR-T, preparation involves a comprehensive medical evaluation, including imaging, blood tests, and tumor biopsy. Once eligible, we will discuss the specifics of the procedure and coordinate logistics for your stay in China.
Q.
Can I bring a companion with me during treatment?

A.

Yes, we encourage patients to bring a family member or friend for support during their stay. We provide assistance with accommodation and travel arrangements for your companion.
Q.
How do I arrange travel to BIOOCUS for treatment?

A.

BIOOCUS provides comprehensive support for international patients, including visa assistance, flight recommendations, and accommodation arrangements. We will guide you through the process and ensure a smooth arrival.
Q.
How much does TIL therapy cost at BIOOCUS?

A.
The cost for TIL therapy at BIOOCUS typically ranges from $100,000 to $150,000 USD, depending on the complexity of the treatment and required follow-up care.
Q.
What happens if I need additional TIL therapy after the first infusion?

A.
If TIL therapy proves to be beneficial, but cancer returns, additional infusions may be considered. We will monitor your progress and discuss any further treatment options after the initial infusion.
Q.
What follow-up care is required after TIL therapy?

A.
Following TIL therapy, patients will need regular check-ups to track cancer response and manage any long-term effects. This may include imaging, blood tests, and immune system monitoring.
Q.
Is there a risk of the cancer returning after TIL therapy?

A.
While TIL therapy can offer durable remissions, there is always a risk of cancer recurrence. Continuous monitoring and follow-up care are essential to detect any signs of relapse early.